GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jubilant Pharmova Ltd (NSE:JUBLPHARMA) » Definitions » Inventory Turnover

Jubilant Pharmova (NSE:JUBLPHARMA) Inventory Turnover : 0.55 (As of Mar. 2025)


View and export this data going back to 2003. Start your Free Trial

What is Jubilant Pharmova Inventory Turnover?

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Jubilant Pharmova's Cost of Goods Sold for the three months ended in Mar. 2025 was ₹6,261 Mil. Jubilant Pharmova's Average Total Inventories for the quarter that ended in Mar. 2025 was ₹11,292 Mil. Jubilant Pharmova's Inventory Turnover for the quarter that ended in Mar. 2025 was 0.55.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Jubilant Pharmova's Days Inventory for the three months ended in Mar. 2025 was 164.57.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Jubilant Pharmova's Inventory-to-Revenue for the quarter that ended in Mar. 2025 was 0.59.


Jubilant Pharmova Inventory Turnover Historical Data

The historical data trend for Jubilant Pharmova's Inventory Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jubilant Pharmova Inventory Turnover Chart

Jubilant Pharmova Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Inventory Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.18 1.50 1.69 1.60 1.92

Jubilant Pharmova Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Inventory Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.41 0.44 0.48 0.49 0.55

Jubilant Pharmova Inventory Turnover Calculation

Jubilant Pharmova's Inventory Turnover for the fiscal year that ended in Mar. 2025 is calculated as

Inventory Turnover (A: Mar. 2025 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (A: Mar. 2025 ) / ((Total Inventories (A: Mar. 2024 ) + Total Inventories (A: Mar. 2025 )) / count )
=23170 / ((12896 + 11292) / 2 )
=23170 / 12094
=1.92

Jubilant Pharmova's Inventory Turnover for the quarter that ended in Mar. 2025 is calculated as

Inventory Turnover (Q: Mar. 2025 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (Q: Mar. 2025 ) / ((Total Inventories (Q: Dec. 2024 ) + Total Inventories (Q: Mar. 2025 )) / count )
=6261 / ((0 + 11292) / 1 )
=6261 / 11292
=0.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jubilant Pharmova  (NSE:JUBLPHARMA) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Jubilant Pharmova's Days Inventory for the three months ended in Mar. 2025 is calculated as:

Days Inventory =Average Total Inventories (Q: Mar. 2025 )/Cost of Goods Sold (Q: Mar. 2025 )*Days in Period
=11292/6261*365 / 4
=164.57

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Jubilant Pharmova's Inventory to Revenue for the quarter that ended in Mar. 2025 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Mar. 2025 ) / Revenue (Q: Mar. 2025 )
=11292 / 19158
=0.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.


Jubilant Pharmova Inventory Turnover Related Terms

Thank you for viewing the detailed overview of Jubilant Pharmova's Inventory Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Jubilant Pharmova Business Description

Traded in Other Exchanges
Address
1A, Sector 16A, Noida, UP, IND, 201301
Jubilant Pharmova Ltd is an integrated pharmaceutical company. The company operates in the following segments; Radiopharma; Allergy Immunotherapy; Contract Development and Manufacturing Organisation - Sterile Injectables; Generics; Contract Research, Development and Manufacturing Organisation; and Proprietary Novel Drugs. It generates maximum revenue from the Radiopharma segment which specializes in developing, manufacturing, commercializing, and distributing therapeutic agents in the nuclear medicine domain. Geographically, it derives a majority of its revenue from the Americas and Europe and the rest from India and the Rest of the world.

Jubilant Pharmova Headlines

No Headlines